Myeloproliferative disorders (MPD): Myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia

Seminars in Hematology

Volumn 12, Issue 4, 1975, Pages 409-432

  Laszlo, John ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC MYELOID LEUKEMIA; DIAGNOSIS; EXTRAMEDULLARY HEMATOPOIESIS; HISTOLOGY; MAJOR CLINICAL STUDY; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; REVIEW; SPLENOMEGALY; THERAPY; THROMBOCYTHEMIA;

ANEMIA; CHROMOSOME ABERRATIONS; ERYTHROCYTES, ABNORMAL; FEMALE; HEMATOPOIESIS; HISTAMINE; HISTIDINE DECARBOXYLASE; HUMAN; LEUKOCYTE COUNT; MALE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 0016776911     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (106)

1. Myelofibrosis with myeloid metaplasia in survivors of the atomic bomb in Hiroshima
2. Leukokinetic studies. XI. Blood granulocyte kinetics in polycythemia vera infection, and myelofibrosis
3. The syndrome of paroxysmal nocturnal hemoglobinuria
4. Hemorrhagic thrombocythemia; control of postsplenectomy thrombocytosis with melphalan
5. Abnormalities of platelet function in patients with polycythemia vera
6. Acute myelofibrosis: An accelerated variant of agnogenic myeloid metaplasia
7. Myeloid metaplasia: Clinical, laboratory and cytogenetic observations
8. Aspirin and painful toes and fingers in thrombocythemia
9. Muramidase in polycythemia vera
10. Spleen blood flow and splanchnic haemodynamics in blood dyscrasia and other splenomegalies
11. Ultrastructural alterations of the blood platelets in a case of osteomyelosclerosis with thrombocythemia (IT)
12. Myelofibrosis: Clinical hematologic and pathologic study of 110 patients
13. Primary myeloid metaplasia
14. The reticulin content of bone marrow in haematological disorders
15. Abnormalities of platelet function in the myeloproliferative disorders
16. Case Records of the Massachusetts General Hospital
17. Increase in circulating stem cells in patients with myelofibrosis
18. Syndrome of myelofibrosis. Report of 8 cases
19. Foreword and a proposal for considering paroxysmal nocturnal hemoglobinuria (PNH) as a “candidate” myeloproliferative disorder
20. (Editorial) Some speculations on the myeloproliferative syndromes
21. Paroxysmal nocturnal hemoglobinuria. Atypical manifestations suggesting an immunological disease
22. Therapy of the myeloproliferative disorders with Myleran
23. Abnormal platelet function in myelofibrosis
24. Hamorrhägische Thrombocythämie bei vasculären Schrumpfmilz
25. Paroxysmal nocturnal haemoglobinuria and leukaemia
26. Androgens and erythropoiesis. II. Treatment of myeloid metaplasia
27. A reappraisal of the “myeloproliferative disease” concept
28. The spectrum of myeloproliferative disorders
29. 12-binding capacity in myeloproliferative disease
30. A study of histamine in myeloproliferative disease
31. Transitions among the myeloproliferative disorders
32. Myeloid metaplasia with myelofibrosis. The clinical spectrum of extramedullary hematopoiesis and tumor formation
33. Specificity of the Philadelphia chromosome. Cytogenic studies in cases of chronic myelocytic leukemia and myeloid metaplasia
34. Splenectomy for myeloid metaplasia of the spleen
35. Hemorrhagic thrombocythemia: a critical review
36. Essential thrombocythemia
37. Paroxysmal nocturnal hemoglobinuria in myelofibrosis
38. Haemorrhagic thrombocythaemia: A clinical and laboratory study
39. Thrombokinetics in man
40. Zuile Falle von Laukasmie mit eigen thumlichend Blut risp Knochenmarkbefund
41. Treatment of patients with myelosclerosis
42. Leukaemia and related conditions and the blood uric acid
43. The serum Lactobacillus casei: folate clearance test in various hematologic disorders
44. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets
45. Effect of androgenic hormone in myelofibrosis
46. The relationship of the reticulum to diseases of the hematopoietic system
47. Prognosis in the myelofibrosis-myeloid metaplasia syndrome
48. Myeloproliferative diseases. Diagnostic value of the leukocyte alkaline phosphatase test
49. On myelofibrosis
50. Leukocyte histidine decarboxylase: Properties and activity in myeloproliferative disorders
51. Leukemia in polycythemia vera: relationship to splenic myeloid metaplasia and therapeutic radiation dose
52. The nature and treatment of polycythemia: studies on 263 patients
53. Myelosclerosis and paroxysmal haemoglobinuria
54. Malignant myelosclerosis
55. Extramedullary myeloid tumors in primary myelofibrosis
56. Melphalan therapy of polycythemia vera
57. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative diseases. II. Ultrastructure of circulating megakaryocytes
58. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative diseases. I. The platelets: ultrastructural and peroxidase reaction
59. Platelet function tests in thrombocythaemia and thrombocytosis
60. Hemorrhagic thrombocythemia; rapid platelet-pheresis by continuous flow blood cell separation
61. Megakaryocytes in the peripheral circulation
62. Erythremia (polycythemia rubra vera) The development of anemia; the relation to leukemia; consideration of basal metabolism blood formation and destruction and fragility of the red cells
63. Alkaline phosphatase of mature neutrophils in chronic forms of the myeloproliferative syndrome
64. Bone changes in myelosclerosis
65. Agnogenic myeloid metaplasia A survey of twenty-nine cases and a review of the literature
66. Chromosome studies in human leukemia. IV. Myeloproliferative syndrome and other atypical myeloid disorders
67. Osteomyelosklerose und sketell
68. Portal hypertension in myeloid metaplasia: report of a case without apparent portal obstruction
69. Correlation of radiologic, histologic and clinical findings in agnogenic myeloid metaplasia
70. A clinical and pathological study of seventy cases of myelofibrosis
71. Myeloid metaplasia as a result of chronic benzene intoxication
72. Myelofibrose und osteomyelosklerose (osteomyeloretikulose-syndrom)
73. Hemodynamic studies of the portal circulation in myeloid metaplasia
74. Myeloid metaplasia: A study of 98 cases
75. Myeloproliferative disorders with documented leukemic transformation
76. Clinical and hematological studies on Banti's disease I The blood platelet factor with reference to splenectomy
77. Myeloproliferative disorders—general considerations
78. Comparison of chromosome constitution in chronic myelocytic leukemia and other myeloproliferative disorders
79. Group-C trisomy in myeloid metaplasia with possible leukemia
80. Agnogenic myeloid metaplasia and the Budd-Chiari syndrome
81. Use of testosterone and busulfan in the treatment of myelofibrosis with myeloid metaplasia
82. Postpolycythemia myeloid metaplasia
83. Agnogenic myeloid metaplasia: natural history and treatment
84. Causes of death in agnogenic myeloid metaplasia
85. Sex, spenetomy and myeloid metaplasia
86. Gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia
87. Muramidase activity in leukemic and myeloproliferative disorders
88. Hemorrhagic thrombocythemia a blood coagulation disorder
89. Defective platelets in essential thrombocythemia
90. Paroxysmal nocturnal haemoglobinuria and chronic myeloid leukaemia in the same patient
91. Le traitement des thrombocythemies par le phosphore radioactif
92. Biochemical studies in chronic myelocytic leukemia, polycythemia vera, and other idiopathic myeloproliferative disorders
93. Markedly increased bone blood flow in myelofibrosis
94. Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis
95. Leucoerythroblastic anaemia and myelosclerosis
96. Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers
97. Leukocyte kinetics in hematologic disorders studied by DNA-phosphorus labeling
98. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome
99. Polycythemia vera—its course and treatment: Relation to myeloid metaplasia and leukemia
100. Hémorragies et thromboses au cours de la thrombocythémie essentielle (a propos de 3 observations personnelles)
101. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies
102. Chronic marrow failure, myelosclerosis, and extramedullary hematopoiesis
103. Secondary gout associated with myeloproliferative diseases